A Phase I, Open-Label Study of Trebananib Combined With...

Clinical Genitourinary Cancer 2014 / 06 Vol. 12; Iss. 3

A Phase I, Open-Label Study of Trebananib Combined With Sorafenib or Sunitinib in Patients With Advanced Renal Cell Carcinoma

Hong, David S., Gordon, Michael S., Samlowski, Wolfram E., Kurzrock, Razelle, Tannir, Nizar, Friedland, David, Mendelson, David S., Vogelzang, Nicholas J., Rasmussen, Erik, Wu, Benjamin M., Bass, Mich
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
12
Language:
english
Journal:
Clinical Genitourinary Cancer
DOI:
10.1016/j.clgc.2013.11.007
Date:
June, 2014
File:
PDF, 1.39 MB
english, 2014
Conversion to is in progress
Conversion to is failed